vidarabine has been researched along with ATLL in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Ashida, N; Ijichi, K; Machida, H; Matsuda, A; Sakata, S; Satoh, H; Watanabe, M; Yoshimura, Y | 1 |
| Atsuta, Y; Eto, T; Fuji, S; Fukuda, T; Inoue, Y; Kanda, J; Kato, K; Kawakita, T; Kondo, T; Miyamoto, T; Nakano, N; Sawayama, Y; Suehiro, Y; Uchida, N; Yoshimitsu, M | 1 |
| Higashi, T; Hirosawa, M; Kominato, Y; Morimoto, H; Tanaka, A; Tsukada, J; Yamaguchi, T | 1 |
| Conlon, KC; Jaffe, ES; Kreitman, RJ; Pastan, I; Steinberg, SM; Stetler-Stevenson, M; Waldmann, TA; Wilson, W | 1 |
| Escherich, G; Hassenpflug, WA; Horstmann, MA; Janka, G; Kabisch, H; zur Stadt, U | 1 |
| Curbo, S; Karlsson, A | 1 |
| Oh-hara, T; Tsuruo, T; Yusa, K | 1 |
| Egle, A; Geley, S; Greil, R; Hartmann, BL; Kofler, R; Kos, M; Villunger, A | 1 |
| Baudet, S; Binet, JL; Blanc, C; Issaly, F; Mentz, F; Merle-Beral, H | 1 |
| Bamborschke, S; Diehl, V; Fätkenheuer, G; Lehrke, R; Re, D; Reiser, M; Salzberger, B; Schröder, R; Tesch, H | 1 |
| Allen, PD; Kelsey, SM; Newland, AC; Richardson, DS | 2 |
| Akutsu, M; Bai, L; Furukawa, Y; Ichikawa, A; Kano, Y; Kon, K; Suzuki, K; Tsunoda, S | 1 |
1 review(s) available for vidarabine and ATLL
| Article | Year |
|---|---|
Nelarabine: a new purine analog in the treatment of hematologic malignancies.
Topics: Arabinonucleosides; Clinical Trials as Topic; DNA Repair; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Leukemia-Lymphoma, Adult T-Cell; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome; Vidarabine | 2006 |
2 trial(s) available for vidarabine and ATLL
| Article | Year |
|---|---|
Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission.
Topics: Aged; Allografts; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Female; Follow-Up Studies; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Vidarabine; Viral Load; Whole-Body Irradiation | 2020 |
Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Exotoxins; Female; Humans; Immunotoxins; Interleukin-2 Receptor alpha Subunit; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Remission Induction; Treatment Outcome; Vidarabine | 2016 |
10 other study(ies) available for vidarabine and ATLL
| Article | Year |
|---|---|
A facile, alternative synthesis of 4'-thioarabinonucleosides and their biological activities.
Topics: Antiviral Agents; Arabinonucleosides; Cell Division; Cell Line; Cytarabine; Cytomegalovirus; Herpesviridae; Humans; Indicators and Reagents; Leukemia-Lymphoma, Adult T-Cell; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thionucleosides; Tumor Cells, Cultured | 1997 |
Impact of conditioning intensity and regimen on transplant outcomes in patients with adult T-cell leukemia-lymphoma.
Topics: Busulfan; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia-Lymphoma, Adult T-Cell; Retrospective Studies; Transplantation Conditioning; Vidarabine | 2021 |
Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Deoxycytidine; Dexamethasone; Drug Evaluation; Drug Synergism; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Infant; Leukemia-Lymphoma, Adult T-Cell; Male; Methylprednisolone; Neoplasm, Residual; Peripheral Blood Stem Cell Transplantation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Recombinant Proteins; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thiotepa; Topotecan; Treatment Outcome; Vidarabine; Vinblastine | 2005 |
Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus.
Topics: Cell Division; Cell Line; Cell Survival; Cytarabine; Cytidine Deaminase; Drug Resistance; Fluorouracil; Humans; Leukemia-Lymphoma, Adult T-Cell; Mercaptopurine; Simian Immunodeficiency Virus; Tetrahydrouridine; Tumor Cells, Cultured; Vidarabine; Zalcitabine; Zidovudine | 1995 |
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Cisplatin; Doxorubicin; Fas Ligand Protein; fas Receptor; Humans; Leukemia-Lymphoma, Adult T-Cell; Ligands; Membrane Glycoproteins; Signal Transduction; Tumor Cells, Cultured; Up-Regulation; Vidarabine | 1997 |
Simple, fast method of detection apoptosis in lymphoid cells.
Topics: Apoptosis; Blood Cell Count; Cells, Cultured; Chlorambucil; Flow Cytometry; Humans; Immunohistochemistry; Interleukin-4; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Reference Values; Scattering, Radiation; Theophylline; Vidarabine | 1998 |
Two cases of toxoplasmic encephalitis in patients with acute T-cell leukaemia and lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; HIV Seronegativity; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell; Male; Meningoencephalitis; Methotrexate; Middle Aged; Toxoplasmosis; Vidarabine | 1999 |
Inhibition of FAS/FAS-ligand does not block chemotherapy-induced apoptosis in drug sensitive and resistant cells.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Cell Cycle; Clone Cells; Drug Resistance, Multiple; Etoposide; Fas Ligand Protein; fas Receptor; HL-60 Cells; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured; Vidarabine; Vinblastine | 1999 |
Effects of PARP inhibition on drug and Fas-induced apoptosis in leukaemic cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Drug Resistance, Multiple; Enzyme Inhibitors; Etoposide; fas Receptor; Genes, MDR; HL-60 Cells; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Microtubules; Phenanthrenes; Poly(ADP-ribose) Polymerase Inhibitors; Tumor Cells, Cultured; Vidarabine; Vinblastine | 1999 |
In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Methotrexate; Neoplastic Stem Cells; Tumor Cells, Cultured; Vidarabine; Vidarabine Phosphate; Vincristine | 2000 |